Deutetrabenazine API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: USP grade or in-house specification
Reference Brands: Austedo, Austedo XR
Category: Active Pharmaceutical Ingredient
Deutetrabenazine is a deuterated VMAT2 inhibitor used for Huntington's chorea and tardive dyskinesia. It is sourced by generic formulators, CDMOs and R&D teams.
Manufacture or export Deutetrabenazine API? List it or send an offer →
Product Description:
Deutetrabenazine is a version of tetrabenazine in which the six hydrogen atoms on its two methoxy groups are replaced with deuterium, which slows its breakdown in the body. Like tetrabenazine it inhibits vesicular monoamine transporter 2 (VMAT2), reducing the release of dopamine in the brain. It is approved in the US for adults with chorea associated with Huntington's disease and with tardive dyskinesia (reference brand: Austedo, Austedo XR).
Specification at a glance
| Traded form | Racemic (RR, SS) free base; white to slightly yellow crystalline powder, sparingly soluble in water. |
|---|---|
| CAS number | 1392826-25-3 |
| Molecular formula | C19H21D6NO3 |
| Molecular weight | 323.5 g/mol |
| Pharmacopoeia | No official monograph found; USP lists deutetrabenazine and deutetrabenazine tablets as new monographs in development. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 7 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Entry expected (Apr 2033 (settlements)). European Union: No confirmed date.
Handling and quality points
The extra test that sets deutetrabenazine apart is isotopic purity: ask how the supplier measures deuterium incorporation and limits partly deuterated species, usually by mass spectrometry or NMR. Stereochemistry needs control too, since the drug is the racemic RR/SS pair and the other diastereomers count as impurities. The finished product must be protected from light and moisture, so check the drug substance stability data on the same points.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Deutetrabenazine API — third party manufacturing & bulk supply
Deutetrabenazine API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Deutetrabenazine API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Deutetrabenazine API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Deutetrabenazine API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Usually a GMP certificate, the specification and certificate of analysis with isotopic purity results, and a US DMF letter of access where one exists. Stability data, a nitrosamine risk assessment and a residual solvent statement complete the core set.
Specifications normally set a minimum for the fully d6 species and limits for lower isotopologues, measured by mass spectrometry and sometimes backed by NMR. Ask to see the method and several batches of data, because the deuterated starting material largely decides what can be achieved.
Yes. We connect licensed manufacturers, CDMOs and R&D teams with GMP-compliant makers of deuterated APIs, and we review the supplier's documents first. Your details are only shared once both sides agree.
Related Products
Osimertinib Mesylate API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Tagrisso
View DetailsTucatinib API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Tukysa
View DetailsFerumoxytol API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Feraheme, Rienso
View DetailsDegarelix Acetate API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Firmagon
View DetailsFerric Derisomaltose API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Monoferric, Monofer
View DetailsTrabectedin API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Yondelis
View DetailsNusinersen Sodium API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Spinraza
View DetailsPonatinib Hydrochloride API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Iclusig
View DetailsUsually answered within 48 hours | GMP documents shared before you commit